Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.5K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative study on the efficacy of conservative treatment and surgical treatment for simple Mason II radial head fracture.

Frontiers in surgery·2026
Same author

Progress in the treatment of complex osteoporotic proximal humeral fractures in elderly patients.

Frontiers in surgery·2026
Same author

Detection of a group of classic serum tumor markers (CSTMs) aids in the differential diagnosis and disease assessment of upper tract urothelial carcinoma (UTUC).

Translational andrology and urology·2026
Same author

Template-based pelvic lymph node dissection during lateral decubitus-positioned total retroperitoneal laparoscopic radical nephroureterectomy: a step-by-step description of a surgical technique.

Translational andrology and urology·2026
Same author

Alopecia Areata With an FFA-Like Phenotype: Clinicopathologic Features and Treatment Outcomes in a Prospective Cohort.

International journal of dermatology·2026
Same author

A Probiotic Combination of Limosilactobacillus reuteri and Clostridium butyricum Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis in Rats by Strengthening Barrier Integrity and Modulating Immuno-Microbial Homeostasis.

Journal of cellular physiology·2026

Related Experiment Video

Updated: Jun 8, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

Causal correlations between inflammatory proteins and heart failure: A two-sample Mendelian randomization analysis.

Xian-Guan Zhu1, Gui-Qin Liu1,2, Ya-Ping Peng1,3

  • 1Department of Cardiology, Anqing Municipal Hospital, Anqing, China.

ESC Heart Failure
|November 6, 2024
PubMed
Summary

This study used Mendelian randomization to link inflammation-related proteins to heart failure (HF) risk. Matrix metalloproteinase-1 (MMP-1) and TNF-beta are associated with increased HF risk, while urokinase-type plasminogen activator (uPA) shows a protective effect.

Keywords:
Heart failureInflammatory proteinsMatrix metalloproteinase‐1Mendelian randomizationMeta‐analysisTNF‐betaUrokinase‐type plasminogen activator

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.5K

Related Experiment Videos

Last Updated: Jun 8, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.5K

Area of Science:

  • Genetics and Cardiovascular Disease
  • Inflammation and Immunology
  • Biomarker Discovery

Background:

  • Inflammation is a key factor in heart failure (HF) development and progression.
  • The causal links between specific inflammatory proteins and HF risk are not fully understood.
  • Identifying these links can reveal new therapeutic targets for HF.

Purpose of the Study:

  • To investigate the genetically supported causal relationships between inflammation-related proteins and HF risk.
  • To utilize a two-sample Mendelian randomization (MR) approach for robust analysis.
  • To identify specific inflammatory proteins that may influence HF development.

Main Methods:

  • Employed a two-sample Mendelian randomization (MR) analysis using genome-wide association study (GWAS) data.
  • Utilized data from the SCALLOP Consortium for 91 inflammation-related proteins and large-scale HF GWAS datasets (FinnGen and HERMES).
  • Selected instrumental variables (IVs) based on established MR assumptions and assessed associations using various statistical methods, including inverse-variance weighted (IVW) and MR-Egger regression.

Main Results:

  • Identified significant associations between three inflammatory proteins and HF risk.
  • Matrix metalloproteinase-1 (MMP-1) and TNF-beta showed a positive association with increased HF risk in the FinnGen cohort.
  • Urokinase-type plasminogen activator (uPA) demonstrated an inverse association, suggesting a protective effect against HF in both FinnGen and HERMES cohorts.

Conclusions:

  • Provided genetically supported evidence for causal links between specific inflammatory proteins and HF risk.
  • MMP-1 and TNF-beta may contribute to HF pathogenesis, while uPA might offer a protective role.
  • These findings suggest that targeting specific inflammatory pathways could be a viable therapeutic strategy for managing HF.